NCT01807091View on ClinicalTrials.gov

Outpatient Induction Chemotherapy in Treating Patients With Acute Myeloid Leukemia or Advanced Myelodysplastic Syndrome

NACompletedINTERVENTIONAL
Enrollment

17

Participants

Timeline

Start Date

May 21, 2013

Primary Completion Date

January 8, 2020

Study Completion Date

January 8, 2020

Conditions
Adult Acute Myeloid LeukemiaAdult Myelodysplastic Syndrome
Interventions
DRUG

Chemotherapy

Receive outpatient induction chemotherapy

Trial Locations (9)

59715

Bozeman Deaconess Hospital, Bozeman

98033

EvergreenHealth Medical Center, Kirkland

98052

Group Health Cooperative, Redmond

98109

Fred Hutch/University of Washington Cancer Consortium, Seattle

98274

Skagit Valley Hospital, Mount Vernon

98362

Olympic Medical Center, Port Angeles

98415

Multicare Health System, Tacoma

98801

Wenatchee Valley Hospital and Clinics, Wenatchee

99336

Kadlec Clinic Hematology and Oncology, Kennewick

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

University of Washington

OTHER

NCT01807091 - Outpatient Induction Chemotherapy in Treating Patients With Acute Myeloid Leukemia or Advanced Myelodysplastic Syndrome | Biotech Hunter | Biotech Hunter